Methylation of multiple genes in hepatitis C virus associated hepatocellular carcinoma

Journal of Advanced Research

Volumn 5, Issue 1, 2014, Pages 27-40

  Zekri, Abdel Rahman N ^a   Bahnasy, Abeer A ^b   Shoeab, Fatma elzahraa M ^d   Mohamed, Waleed S ^a   El Dahshan, Dina H ^c   Ali, Fahmey T ^d   Sabry, Gilane M ^d   Dasgupta, Nairajana ^e   Daoud, Sayed S ^e  

^a CAIRO UNIVERSITY   (Egypt)

^b NATIONAL CANCER INSTITUTE   (Egypt)

^c BENI SUEF UNIVERSITY   (Egypt)

^d Ain Shams University   (Egypt)

^e WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Chronic hepatitis; Hepatitis C virus genotype 4; Hepatocellular carcinoma; Promoter methylation

Indexed keywords

EID: 84892593021     PISSN: 20901232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jare.2012.11.002     Document Type: Article

References (34)

1. El-Serag H.B. Epidemiology of hepatocellular carcinoma in USA. Hepatol Res 2007, 2:S88-S94.
2. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
3. Anwar W.A., Khaled H.M., Amra H.A., El-Nezami H., Loffredo C.A. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention. Mutat Res 2008, 659(1-2):176-184.
4. Lau W., Lai E.C.H. Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int 2008, 7(3):237-257.
5. Lehman E.M., Wilson M.L. Epidemiology of hepatitis viruses among hepatocellular carcinoma cases and healthy people in Egypt: a systematic review and meta-analysis. Int J Cancer 2009, 124(3):690-697.
6. Baylin S.B., Herman J.G. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 2000, 16:168-174.
7. Feinberg A.P. Cancer epigenetics takes center stage. Proc Natl Acad Sci USA 2001, 98:392-394.
8. Zhang C., Li H., Zhou G., Zhang Q., Zhang T., Li J., et al. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells. J Pathol 2007, 212(2):134-361.
9. Teodoridis J.M., Hardie C., Brown R. CpG island methylator phenotype (CIMP) in cancer: causes and implications. Cancer Lett 2008, 268(2):177-355.
10. Tsou J.A., Galler J.S., Wali A., Ye W., Siegmund K.D., Groshen S., et al. DNA methylation profile of 28 potential marker loci in malignant mesothelioma. Lung Cancer 2007, 58(2):220-230.
11. Lehman E.M., Wilson M.L. Epidemiology of hepatitis viruses among hepatocellular cases and healthy people in Egypt: a systematic review and meta-analysis. Int J Cancer 2009, 24:690-697.
12. Hamilton S.R., Aaltonen L.A. World health organization classification of tumors. Pathology and genetics of tumors of digestive system 2000, IARC Press, Lyon, p. 157-202.
13. Green FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, et al., editors. AJCC Cancer Staging Manual, 6th ed. New York: Springer; 2002.
14. Ishak K., Baptista A., Bianchi L., Callea F., Degroote J., Denk F. Histopathological staging and grading of chronic hepatitis. J Hepatol 1995, 22:696-699.
15. Iyer P., Zekri A.R., Hung C.W., Schiefelbein E., Ismail K., Hablas S., et al. Concordance of DNA methylation pattern in plasma and tumor DNA of Egyptian hepatocellular carcinoma patients. Exp Mol Pathol 2010, 88:107-111.
16. Gutiérrez M.I., Siraj A.K., Bhargava M., Ozbek U., Banavali S., Chaudhary M.A., et al. Concurrent methylation of multiple genes in childhood ALL: correlation with phenotype and molecular subgroup. Leukemia 2003, 17:1845-1850.
17. Bahnassy A.A., Zekri A.R., Loutfy S.A., Mohamed W.S., Abdel Moneim A., Salem E.S. The role of cyclins and cyclin dependent kinases in development and progression of hepatitis C virus-genotype 4-associated hepatitis and hepatocellular carcinoma. Exp Mol Pathol 2011, 91:643-652.
18. Berdasco M., Esteller M. Aberrant epigenetic landscape in cancer: how cellular identity goes away. Dev Cell 2010, 19:698-711.
19. Zaina S., Pérez-Luque E.L., Lund G. Genetics talks to epigenetics? The interplay between sequence variants and chromatin structure. Curr Genom 2010, 11:359-367.
20. Archer K.J. High-throughput assessment of CpG site methylation for distinguishing between HCV-cirrhosis and HCV-associated hepatocellular carcinoma. Mol Genet Genom 2010, 283(4):341-349.
21. Hesson L.B., Cooper W.N., Latif F. The role of RASSF1A methylation in cancer. Dis Markers 2007, 23:73-87.
22. Lia Z., Zhangb H., Yangb J., Haoc T., Li S. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma. Cell Biol Int 2012, 36:427-432.
23. Zhong S., Yeo W., Tang M.W., Wong N., Lai P.B., Johnson P.J. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas. Clin Cancer Res 2003, 9:3376-3382.
24. Tischoff I., Markwarth A., Witzigmann H., Uhlmann D., Hauss J., Mirmohammadsadegh A., et al. Allele loss and epigenetic inactivation of 3p21.3 in malignant liver tumors. Int J Cancer 2005, 115:684-689.
25. Gioia S., Bianchi P., Destro A., Grizzi F., Malesci A., Laghi L., et al. Quantitative evaluation of RASSF1A methylation in the non-lesional, regenerative and neoplastic liver. BMC Cancer 2006, 89(6):1471-2407.
26. Chan K.C., Lai P.B., Mok T.S., Chan H.L., Ding C., Yeung S.W., et al. Quantitative analysis of circulating methylated DNA as a biomarker for hepatocellular carcinoma. Clin Chem 2008, 54:1528-1536.
27. ARF gene alterations in human hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2004, 16:19-26.
28. Yang B., Guo M., Herman J.G., Clark D.P. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am J Pathol 2003, 163(3):1101-1107.
29. Esteller M., Tortola S., Toyota M., Capella G., Peinado M.A., Baylin S.B., et al. Hypermethylation-associated inactivation of p14 (ARF) is independent of p16 (INK4a) methylation and p53 mutational status. Cancer Res 2000, 60:129-133.
30. Vivekanandan P., Torbenson M. Epigenetic instability is rare in fibrolamellar carcinomas but common in viral-associated hepatocellular carcinomas. Modern Pathol 2008, 21:670-675.
31. Lenz G., Hutter G., Hiddemann W., Dreyling M. Promoter methylation and expression of DNA repair genes hMLH1 and O6-MGMT in acute myeloid leukemia. Ann Hematol 2004, 83:628-633.
32. Nomoto S., Kinoshita T., Kato K., Otani S., Kasuya H., Takeda S., et al. Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma. Br J Cancer 2007, 97:1260-1265.
33. Matsukura S., Soejima H., Nakagawachi T., Yakushiji H., Ogawa A., Fukuhara M., et al. CpG methylation of O6-MGMT and hMLH1 promoter in hepatocellular carcinoma associated with hepatitis viral infection. Br J Cancer 2003, 88:521-529.
34. Matsumura T., Makino R., Mitamura K. Frequent downregulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas. Clin Cancer Res 2001, 20017:594-599.